Latest News Feed
Tweeted
Nov 21, 2025
Massive Bio
@MassiveBio Lung Cancer Awareness Month reminds us how important clarity and support are when life feels uncertain. If you are exploring clinical trial options for lung cancer, we can help you understand what may be available. massivebio.com/advanced-nsclc…
Massive Bio
@MassiveBio Lung Cancer Awareness Month reminds us how important clarity and support are when life feels uncertain. If you are exploring clinical trial options for lung cancer, we can help you understand what may be available. massivebio.com/advanced-nsclc…
Tweeted
Nov 14, 2025
Massive Bio
@MassiveBio Massive Bio has introduced Reticulum Nexus, our new multi-agent platform built to coordinate the entire oncology journey, from first contact to last-mile enrollment, at global scale. It brings together clinical, operational, and AI intelligence into one system designed to remove
Massive Bio
@MassiveBio Massive Bio has introduced Reticulum Nexus, our new multi-agent platform built to coordinate the entire oncology journey, from first contact to last-mile enrollment, at global scale. It brings together clinical, operational, and AI intelligence into one system designed to remove
Tweeted
Oct 30, 2025
Massive Bio
@MassiveBio How is AI transforming the way patients access clinical trials? Our Co-founder & CEO Selin Kurnaz, PhD, joins Rosa Hart and Craig Lipset on Nurse Rosa’s INsights podcast to explore how technology is breaking barriers in clinical research. Together, they discuss how AI is
Massive Bio
@MassiveBio How is AI transforming the way patients access clinical trials? Our Co-founder & CEO Selin Kurnaz, PhD, joins Rosa Hart and Craig Lipset on Nurse Rosa’s INsights podcast to explore how technology is breaking barriers in clinical research. Together, they discuss how AI is
Tweeted
Oct 17, 2025
Massive Bio
@MassiveBio #ESMO2025 kicks off today! If innovation drives the future of oncology, access decides who reaches it. We’re here in Berlin to make sure it’s everyone. Schedule a meeting here: https://t.co/A2ut4zBio9 #ESMO2025 #MassiveBio #ClinicalTrialsbit.ly/4nUuC4DBio9 #ESMO2025 #MassiveBio #ClinicalTrials c2sV
Massive Bio
@MassiveBio #ESMO2025 kicks off today! If innovation drives the future of oncology, access decides who reaches it. We’re here in Berlin to make sure it’s everyone. Schedule a meeting here: https://t.co/A2ut4zBio9 #ESMO2025 #MassiveBio #ClinicalTrialsbit.ly/4nUuC4DBio9 #ESMO2025 #MassiveBio #ClinicalTrials c2sV
Tweeted
Oct 8, 2025
Massive Bio
@MassiveBio At Massive Bio, we connect breast cancer patients to clinical trials that match their diagnosis, biomarkers, and needs, free, safe, and fast. 👇
Massive Bio
@MassiveBio At Massive Bio, we connect breast cancer patients to clinical trials that match their diagnosis, biomarkers, and needs, free, safe, and fast. 👇
Tweeted
Oct 8, 2025
Massive Bio
@MassiveBio Clinical trials aren’t “experimental risks.” They’re how tomorrow’s options become available today. 👇
Massive Bio
@MassiveBio Clinical trials aren’t “experimental risks.” They’re how tomorrow’s options become available today. 👇
Tweeted
Oct 8, 2025
Massive Bio
@MassiveBio Only a small fraction of eligible patients ever access clinical trials. Not because they can’t, but because no one tells them they can. 👇
Massive Bio
@MassiveBio Only a small fraction of eligible patients ever access clinical trials. Not because they can’t, but because no one tells them they can. 👇
Tweeted
Oct 8, 2025
Massive Bio
@MassiveBio Most breast cancer patients never hear this crucial fact. And it changes everything. 👇
Massive Bio
@MassiveBio Most breast cancer patients never hear this crucial fact. And it changes everything. 👇
